ICBT for Children With FAPDs - the Child's Pain Regulation

March 4, 2024 updated by: Maria Lalouni, Karolinska Institutet

Individualized Online Cognitive Behavioral Therapy for Children With Functional Abdominal Pain Disorders - the Child's Pain Regulation

Functional abdominal pain disorders (FAPDs) in children are common (14%) and abdominal pain has increased rapidly in children during the last ten years in Sweden. Many children with FAPDs have low quality of life, missed school days, and about 30-40% suffer from psychiatric comorbidity. FAPDs are often sustained into adulthood and a large Swedish cohort study showed that abdominal pain during childhood is an independent strong predictor anxiety and depression later in life. Internet-cognitive behavioral therapy (Internet-CBT) can improve FAPD symptoms, but a significant number of children does not respond to the treatment.

We will here determine the pain regulation in children with FAPDs, compared with healthy controls, and assess:

What aspects of the child's pain regulation is related to improvement for children with FAPDs engaging in Internet-CBT?

Does some aspects of the child's pain regulation change during treatment?

Study Overview

Study Type

Observational

Enrollment (Estimated)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Karolinska Institutet
      • Stockholm, Karolinska Institutet, Sweden, 17177

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Children (n=40) aged 8-17 with FAPDs who are patients at BUP Internetbehandling within the Child and Adolescent Psychiatry in Stockholm will be included in the study. Their behavioral and neural pain mechanisms will be assessed before and after Internet-CBT. We will also recruit healthy control children (n=40) aged 8-17 to compare the pain regulation between the groups. First, we will ask whether there are healthy siblings to the participating children with FAPDs that are willing to participate. If we don't get enough children by asking siblings, social media will be used in the recruitment.

Description

Inclusion Criteria:

Children 8-17 years with FAPDs: Have been offered treatment at BUP Internetbehandling for FAPDs.

Children 8-17 years without FAPDs: Not affected by recurrent (every week) or persistant pain during the last year.

Exclusion Criteria:

Contraindication for MR (metal implant or metal object in body, claustrophobia, pregnancy)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
FAPDs
Children 8-17 years with FAPDs
Ten weekly modules for children and ten weekly modules for parents. Exposure-based cognitive behavioral therapy delivered online with asynchronous support via text messages from psychologists.
Controls
Children 8-17 years without FAPDs

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pressure pain threshold on navel
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Algometer pressure (in kPa) for the pain threshold
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Unpleasantness of pressure pain threshold on navel
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Children rate their unpleasantness on a scale 0-10
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pressure pain threshold on thigh
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Algometer pressure (in kPa) for the pain threshold
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Unpleasantness of pressure pain threshold on thigh
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Children rate their unpleasantness on a scale 0-10
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Conditioned pain modulation
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Conditioned pain: hand in 10°C cold water, test pain: presseure pain thresholds by algometer on the participant's thigh. Difference in pressure pain thresholds with and without the simultaneous conditioned stimuli
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Temporal summation
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Pinprick stimuli of low pain, one time, then repeated 10 times. Pain after repeated stimulus minus pain for the single stimulus.
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Sensory attenuation of pain
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Pressure pain thresholds (kPa) applied by the child or the experimenter. Sensory attenuation = difference in pain threshold between self-induced and experimenter induced
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Resting state fMRI
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Differences in network connectivity (Yeo networks + subcortical areas) and between seed (trunk in the somatosensory cortex) to Yeo brain networks + subcortical areas).
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
fMRI during low pain compared with non-painful tactile stimulus
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Differences in network connectivity (Yeo networks + subcortical areas) and between seed (trunk in the somatosensory cortex) to Yeo brain networks + subcortical areas).
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Pediatric Quality of Life Inventory Gastrointestinal Symptom Scale (PedsQL Gastro)
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Self-assessed questionnaire of abdominal symptoms
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Faces Pain Rating Scale (FACES)
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Self-assessed questionnaire of pain intensity
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Visceral sensitivity Index, child-adapted short version (VSI-C)
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Self-assessed questionnaire of gastrointestinal-specific anxiety
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Irritable bowel syndrome-behavioral responses questionnaire, child-adapted short version (BRQ-C)
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Self-assessed questionnaire of gastrointestinal-specific avoidance and controlling behaviors
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maria Lalouni, PhD, Karolinska Institutet

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2023

Primary Completion (Estimated)

September 1, 2025

Study Completion (Estimated)

September 1, 2025

Study Registration Dates

First Submitted

July 6, 2023

First Submitted That Met QC Criteria

July 6, 2023

First Posted (Actual)

July 14, 2023

Study Record Updates

Last Update Posted (Actual)

March 5, 2024

Last Update Submitted That Met QC Criteria

March 4, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 20223238

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Functional Abdominal Pain Syndrome

Clinical Trials on Internet-delivered cognitive behavioral therapy

3
Subscribe